These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 884878)

  • 1. Prevention by somatostatin of rise in blood pressure and plasma renin mediated by beta-receptor stimulation.
    Rosenthal J; Escobar-Jimenez F; Raptis S
    Clin Endocrinol (Oxf); 1977 Jun; 6(6):455-62. PubMed ID: 884878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renin and blood pressure with beta-adrenergic stimulation and somatostatin].
    Rosenthal J; Escobar-Jimenez F; Raptis S
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():294-6. PubMed ID: 611968
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin on plasma renin activity and blood pressure in patients with essential hypertension.
    Izumi Y; Honda M; Tsuchiya M; Ueda Y; Hatano M
    Endocrinol Jpn; 1980 Aug; 27(4):505-11. PubMed ID: 6109626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of somatostatin on blood pressure and plasma renin activity in the rat.
    Schölkens BA
    Arzneimittelforschung; 1978; 28(5):802-3. PubMed ID: 581959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man.
    Rosenthal J; Raptis S; Escobar-Jimenez F; Pfeiffer EF
    Lancet; 1976 Apr; 1(7963):772-4. PubMed ID: 56589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
    Reid IA; Bui H; Chou L
    Hypertension; 1994 Jan; 23(1 Suppl):I49-53. PubMed ID: 8282375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans.
    Weiskopf RB; Moore MA; Eger EI; Noorani M; McKay L; Chortkoff B; Hart PS; Damask M
    Anesthesiology; 1994 May; 80(5):1035-45. PubMed ID: 8017643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin on plasma renin activity.
    Izumi Y; Honda M; Hatano M
    Endocrinol Jpn; 1979 Jun; 26(3):389-94. PubMed ID: 477626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose atenolol on postural and postprandial changes in heart rate, blood pressure, venous plasma catecholamines, and plasma renin activity.
    de Mey C; Hansen-Schmidt S; Enterling D; Meineke I
    Eur J Clin Pharmacol; 1989; 37(2):121-5. PubMed ID: 2676558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta 1-adrenoceptor agonism on plasma renin activity in normal men.
    Staessen J; Cattaert A; De Schaepdryver A; Fagard R; Lijnen P; Moerman E; Amery A
    Br J Clin Pharmacol; 1983 Nov; 16(5):553-6. PubMed ID: 6139122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise.
    Hespel P; Lijnen P; Vanhees L; Fagard R; Amery A
    J Appl Physiol (1985); 1986 Jan; 60(1):108-13. PubMed ID: 3003020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of aldosterone responses to endogenous and exogenous angiotensin II by somatostatin.
    Jones CR; Millar JA; Lawrie C; Sumner DJ; Reid JL
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):279-84. PubMed ID: 6148164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
    Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
    Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
    Davies R; Payne NN; Slater JD
    Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.